OncLive· @OncLive · X·· 8 天前评分60
正文 · 原文
@BalazsHalmosMD and @DylanFortman preview 14 lung cancer abstracts at #ESMO26, including DeLLphi-305 (LBA3), Krascendo 1 (LBA5), SAFFRON (LBA6), OptiTROP-Lung06 (LBA66), and PERSEE (2614O) @MontefioreNYC @EinsteinMed @UMich @myESMO #lcsm https://t.co/sLUzxhTULk https://t.co/blwwSYaxS4
热度 2 · 1 赞 · 0 回复 · 1 转发
会议摘要
2614ONCT04547504
2614O读摘要原文 →NCT04547504NCT04547504按 - **标题 / Title：** PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 % 对上
- **标题 / Title：** PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %读摘要原文 →来源：OncLive · x.com